Zhejiang Hengtong Stock Hits Day Low of CNY 6.07 Amid Price Pressure

Zhejiang Hengtong Holding Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline today, with its stock price dropping by 4.85% on June 1, 2026. The stock reached an intraday low of CNY 6.07, reflecting a challenging trading session. In terms of performance metrics, the company has seen a 1-week decline of 6.17%, contrasting with a modest 2.28% drop in the China Shanghai Composite index. Over the past month, however, Zhejiang Hengtong has managed to achieve a 12.59% increase, significantly outperforming the broader market, which fell by 1.32%. Looking at longer-term trends, the stock has delivered an impressive 118.71% return over the past year, compared to the China Shanghai Composite's 21.22%. Despite this strong annual performance, the company faces challenges, including a high debt-equity ratio of 8.99% and rising raw material costs, which have increased by 32.65% year-over-year. With a market capitalization of CNY 17,570 million, Zhejiang Hengtong continues to navigate a complex financial landscape, marked by both significant growth and underlying pressures.